Also
- Share via
* Gilead Sciences Inc. said that an experimental pill combining its HIV treatment Truvada with Bristol-Myers Squibb Co.’s popular Sustiva treatment would be scrapped, but that a second version of the pill would be developed and could be submitted to U.S. regulators for approval by year-end.
* Verizon Communications Inc., the largest U.S. telephone company, added 11 channels from Viacom Inc.’s Showtime Networks to a slate of television programming it plans to start selling in the second half of the year.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
